06 April 2023: Clinical Research
Evaluation of the Impact of Remote Monitoring Using the Sharesource Connectivity Platform on Adherence to Automated Peritoneal Dialysis in 51 Patients
Min-Yu Chang 12AEF , Po-Jui Chi 123ABCD , Hsi-Hao Wang 12A , Yi-Che Lee 12A , Li-Chun Ho 12F , Ching-Fang Wu 124CD , Ching-Yang Chen 12DF , Hung-Hsiang Liou 15AF , Shih-Yuan Hung 16AD*DOI: 10.12659/MSM.939523
Med Sci Monit 2023; 29:e939523
Figure 1 Study design. Patients were maintained on a traditional automated peritoneal dialysis machine (HomeChoice, Baxter Healthcare Corporation, Deerfield, IL, USA) for at least 1 week (phase 1), and then changed to HomeChoice Claria (Baxter Healthcare Corporation, Deerfield, IL, USA) without Sharesource for 12 weeks (phase 2). The machines were then connected to Sharesource for another 12 weeks (phase 3). Patients were followed up for 1 year. (Designed in Microsoft Word and converted to JPG).